Authors


Molly Csere, PharmD

Latest:

FDA Approves Ensifentrine, Novel Treatment for Chronic Obstructive Pulmonary Disease

On June 26, 2024, the FDA approved ensifentrine (Ohtuvayre) for the treatment of COPD.


Harry Travis, MBA

Latest:

Asembia Does a Great Job Bringing Professionals Together, Experts Say | Asembia 2025

The Summit provides a rare opportunity for professionals to dive deep into emerging healthcare technologies and treatment models.


Matthew Gavidia

Latest:

COVID-19 Omicron Variant Associated with Lower Risk of Severe Illness vs Delta Variant

Vaccination greatly reduces the probability of experiencing severe COVID-19 in both variants. Adults between the ages of 40 to 59 years saw the most significant reduction in risk when compared to individuals in other age categories.


Jaime Rosenberg

Latest:

Assessing Medicaid Policy Barriers to Gene, Cell Therapies

Researchers of a new paper discuss the inconsistencies between gene and cell therapy indications and payor coverage.


Ilya Petrou, MD

Latest:

The Chronic Complications For Children With T1DM

Part of the risk of developing kidney involvement begins when type 1 diabetes mellitus (T1DM) sets in and establishes itself in the patient, with up to 65% of children experiencing acute kidney injury during T1DM onset, which can further predispose to the development of future chronic kidney disease.


Darlene Dobkowski, MA

Latest:

Combining Keytruda And Chemo May Improve Survival in Advanced Endometrial Cancer

Patients with advanced or recurrent endometrial cancer treated with Keytruda plus chemotherapy had improved progression-free survival compared with chemotherapy alone.


Margaret Emerson, DNP, APRN, PMHNP-BC

Latest:

Ethical, Practical Considerations of Exemptions to Employer Vaccine Mandates for Anxiety

Does anxiety justify an exemption from vaccine mandates among health care workers?


Rosanna Sutherby, PharmD

Latest:

Fertility Treatments Equally Effective in Women With, Without PCOS

Women with PCOS were more likely to begin fertility treatment with ovulation induction compared to those without PCOS.



Hailey Choi, PharmD, BCACP, CDCES

Latest:

Wicked Good Cardiometabolic Chat: Compounded Weight Loss Medications

In the first episode of the podcast, Jennifer Goldman and Hailey Choi discuss the latest FDA updates around compounded weight loss medications, clinical concerns and how pharmacists can protect their patients.


Rachel Meyers, PharmD

Latest:

New Drug Approvals in Pediatrics

This past year has seen several important new drug approvals and labeling updates for children. Here is what you should know.


Patrick Campbell

Latest:

Advanced Hybrid Closed-Loop Technology Could Improve Quality of Life in Type 1 Diabetes

A 1-year observational follow-up of a 3-month randomized controlled trial provides insight into the benefits of advanced hybrid closed-loop system use in people with type 1 diabetes using multiple daily injections and self-monitoring of blood glucose.


Todd Shryock

Latest:

Many People Still Unaware Of Telehealth's Efficacy

Despite telehealth’s rise in popularity during the height of COVID-19, many individuals still aren't aware that it's a viable option.


Bernard Esquivel, MD, PhD, MHA, Chief Medical Officer, GenXys Health Care Systems

Latest:

Precision Prescribing Can Advance Mental Health Treatment

Pharmacogenetics can inform precision prescribing practices, which in turn can solve the inefficiencies of current prescribing models.


Antonia Biggs, PhD

Latest:

As Support for Medication Abortion Grows, Pharmacists Can Be Patient Advocates

A conversation with Antonia Biggs, PhD, professor and acting director of the Advancing New Standards in Reproductive Health Program at the University of California, San Francisco.


David Swenson, RPh

Latest:

The Pharmacist-Developed Tool Helping Mitigate Drug Shortages

In a world where drug shortages are one of the most pressing issues for pharmacy businesses, there are certain tools making a significant difference in helping patients access their drugs at the pharmacy.


Hazel Billings-Chiu, PharmD candidate

Latest:

FDA Approves Oral Treatment for Postpartum Depression

Last August, zuranolone (Zurzuvae) became the first FDA-approved pill to treat postpartum depression in adults.


Keith A. Reynolds

Latest:

Vaccine Update: FDA Approves Moderna COVID-19 Vaccine

Spikevax is now the second COVID-19 vaccine approved by regulators.


Candida Ruesga, Esq

Latest:

Where PBM Reform is Headed in 2025, Beyond | NCPDP 2025

Attorneys from The Phoenix Law Group joined Drug Topics at NCPDP 2025 to discuss the current state of pharmacy benefit manager reform and where it may end up in the near future.


Tracy Nguyen, PharmD candidate

Latest:

Navigating Pediatric ADHD Medication Shortages

Stimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.


Kelly Goode, PharmD, BCPS, FAPhA, FCCP

Latest:

Vaccines Show Efficacy, Safety in Preventing Diseases | APhA 2025

Kelly Goode, PharmD, BCPS, FAPhA, FCCP, professor in the department of pharmacotherapy and outcomes science at Virginia Commonwealth University, discusses the current landscape of immunization recommendations.


Lauren Massaro

Latest:

OTC Product Roundup: Sleep Aids

Whether due to jet lag, stress, major life events, or something else, there are a lot of issues that can cause short-term insomnia. Send patients on their way to a better night’s sleep with these OTC sleep aid recommendations.


MHE Staff

Latest:

Oncology Drug Exkivity to be Voluntarily Withdrawn From US Market

Exkivity remains available while Takeda works with the FDA on withdrawal timing, and the company said that patients currently taking the therapy will continue to have access after it is withdrawn.


Marissa Fox

Latest:

Dry Eye Linked to Poor Sleep Quality

All components of sleep quality were reduced significantly in individuals with dry eye disease.


Nina Cosdon

Latest:

Certain Factors May Increase Long COVID Risk in Children

Children who tested positive were more likely to report long COVID symptoms at 90 days than children who tested negative.



Dan Langerman, Langermania

Latest:

Now #Trending: Picking and Choosing Items to Stock the Front-End

Tapping into nostalgia is one way to guide front-end stock choices.


Mariam Zedan, PharmD

Latest:

New Drug Review: FDA Approves Lazertinib Combination Therapy for Non–Small Cell Lung Cancer

Study results show improvement in progression-free survival at 22 months.


Brandon Daniell

Latest:

Texting Can Boost Revenue and Patient Care

Eight ways texting can improve patient retention and boost revenue.


Tony Hagen

Latest:

Sickle Cell Disease Finally Getting Its Due

Two possibly curative gene therapies for the disease, which disproportionately affects Black people, are under consideration by the FDA.

© 2025 MJH Life Sciences

All rights reserved.